Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 7, 1996, Pages 1348-1359

  Crawford, Kathryn S ^a,b   Gange, Stephen J ^c   Gabelt, B'Ann T ^a   Heideman, Warren ^b   Robinson, James C ^a   Hubbard, William C ^a   Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

aqueous humor outflow facility; cyclic adenosine monophosphate; epinephrine; indomethacin; monkey eye

Indexed keywords

ADRENALIN; CYCLIC AMP; INDOMETACIN; PROSTAGLANDIN; PROSTANOID;

ANIMAL EXPERIMENT; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR FLOW; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAOCULAR PRESSURE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN SYNTHESIS INHIBITION;

ADRENERGIC AGONISTS; ANIMALS; AQUEOUS HUMOR; CELL MEMBRANE; CILIARY BODY; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EPINEPHRINE; FEMALE; FORSKOLIN; INDOMETHACIN; IRIS; MACACA FASCICULARIS; OPHTHALMIC SOLUTIONS; TRABECULAR MESHWORK;

EID: 0029884644     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Allen RC, Epstein DL. Additive effects of betaxolol and epinephrine in primary open angle glaucoma. Arch Ophthalmol. 1986;104:1178-1184.
2. Ballintine EJ, Garner LL. Improvement of the coefficient of outflow in glaucomatous eyes: Prolonged local treatment with epinephrine. Arch Ophthalmol. 1961;66:314-317.
3. Schenker JI, Yablonski ME, Podos SM, Linder L. Fluorophotometric study of epinephrine and timolol in human subjects. Arch Ophthalmol. 1981;99:1212-1216.
4. Thomas JV, Epstein DL. Timolol and epinephrine in primary open angle glaucoma transient additive effect. Arch Ophthalmol. 1981;99:91-95.
5. Mandell AI, Stentz F, Kitabchi AE. Dipivalyl epinephrine: A new pro-drug in the treatment of glaucoma. Ophthalmology. 1978;85:268-275.
6. Polansky JR. Beta-adrenergic therapy for glaucoma. Int Ophthalmol Clin. 1990;30:219-229.
7. Mittag TW. Adrenergic and dopaminergic drugs in glaucoma. In: Shields RR, Krupin T, eds. The Glaucomas. St. Louis: CV Mosby; 1989:523-537.
8. Alvarado JA. Epinephrine effects on major cell types of the aqueous outflow pathway: In vitro studies/clinical implications. Trans Am Ophthalmol Soc. 1990; 88:267-288.
9. Townsend DJ, Brubaker RF. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest Ophthalmol Vis Sci. 1980;19:256-266.
10. Richards JSF, Drance SM. The effect of 2% epinephrine on aqueous dynamics in the human eye. Can J Ophthalmol. 1967;2:259-265.
11. Kacere RD, Dolan JW, Brubaker RF. Intravenous epinephrine stimulates aqueous formation in the human eye. Invest Ophthalmol Vis Sci. 1992;33:2861-2865.
12. Erickson-Lamy KA, Nathanson JA. Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro. Invest Ophthalmol Vis Sci. 1992;33:2672-2678.
13. Kaufman PL. Epinephrine, norepinephrine, and isoproterenol dose-outflow facility response relationships in cynomolgus monkey eyes with and without ciliary muscle retrodisplacement. Acta Ophthalmol. 1986;64: 356-363.
14. Robinson JC, Kaufman PL. Effects and interactions of epinephrine, norepinephrine, timolol and betaxolol on outflow facility in the cynomolgus monkey. Am J Ophthalmol. 1990;109:189-194.
15. Bill A. Early effects of epinephrine on aqueous humor dynamics in vervet monkeys (Cercopithecus ethiops). Exp Eye Res. 1969;8:35-43.
16. Polansky JR, Zlock D, Brasier A, Bloom E. Adrenergic and cholinergic receptors in isolated non-pigmented ciliary epithelial cells. Curr Eye Res. 1985;4:517-522.
17. 2-receptor subclasses in antiglaucoma efficacy. J Ocul Pharmacol. 1994;10:359-369.
18. Jampel HD, Lynch MG, Brown RH, Kuhar MJ, De Souza EB. β-adrenergic receptors in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1987;28:772-779.
19. Cynader MS, Gupta M, McAllister R, et al. Mapping the distribution of neurotransmitter receptors, second messenger molecules, and ion channels in the human eye. In: Anderson DR, Drance SM, eds. Encounters in Glaucoma Research 1: Receptor Biology and Glaucoma. Milan: Fogliazza Editore; 1994:301-330.
20. Matsuo T, Cynader MS. Localization of alpha-2 adrenergic receptors in the human eye. Ophthalmic Res. 1992;24:213-219.
21. Farber DB. The role of cyclic nucleotide metabolism in the eye. In: Kebabian JW, Nathanson JA, eds. Cyclic Nucleotides II. New York: Springer-Verlag; 1982:502-524.
22. Caprioli J, Sears ML. Forskolin lowers intraocular pressure in rabbits, monkeys, and man. Lancet. 1983;1: 958-960.
23. Caprioli J, Sears M, Mead A, et al. Adenylate cyclase stimulation and intraocular pressure reduction by forskolin analogs. J Ocul Pharmacol. 1989;5:181-187.
24. Seamon KB, Daly JW. Forskolin: A unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981;7:201-224.
25. Bartels SP, Lee SR, Neufeld AH. The effects of forskolin on cyclic AMP, intraocular pressure and aqueous humor formation in rabbits. Curr Eye Res. 1987;6: 307-320.
26. Laurenza A, Sutkowski EM, Seamon KB. Forskolin: A specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci. 1989;10:442-447.
27. Neufeld AH, Jampol LM, Sears ML. Cyclic-AMP in the aqueous humor: The effects of adrenergic agonists. Exp Eye Res. 1972;14:242-250.
28. Polansky JR, Cherksey BD, Alvarado JA. Update on β-adrenergic drug therapy. In: Drance SM, van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Williams & Wilkins; 1992:301-321.
29. Kaufman PL. Total iridectomy does not alter outflow facility responses to cyclic AMP in cynomolgus monkeys. Exp Eye Res. 1986;43:441-447.
30. Camras CB, Feldman SG, Podos SM, et al. Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans. Am J Ophthalmol. 1985;100:169-175.
31. Camras CB, Podos SM. The role of endogenous prostaglandins in clinically-used and investigational glaucoma therapy. In: Bito LZ, Stjernschantz J, eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R Liss; 1989:459-475.
32. Roy AC, Warren BT. Inhibition of cAMP phosphodiesterase by disodium cromoglycate. Biochem Pharmacol. 1974;23:917-920.
33. Dinnendahl V, Peters HD, Schönhöfer PS. Effects of sodium salicylate and acetylsalicylic acid on cyclic 3′,5′-AMP-dependent protein kinase. Biochem Pharmacol. 1973;22:2223-2228.
34. Northover BJ. Effect of anti-inflammatory drugs on the binding of calcium to cellular membranes in various human and guinea-pig tissues. Br J Pharmacol. 1973;48:496-504.
35. Bito LZ, Camras CB, Gum GG, Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. In: Bito LZ, Stjernschantz J, eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R Liss; 1989: 349-368.
36. Camras CB, Bhuyan KC, Podos SM, Bhuyan DK, Master RWP. Multiple dosing of prostaglandin F2α or epinephrine on cynomolgus monkey eyes: II: Slit-lamp biomicroscopy, aqueous humor analysis, and fluorescein angiography. Invest Ophthalmol Vis Sci. 1987; 28:921-926.
37. Miyake K, Shirasawa E, Hikita M, Miyake Y, Kuratomi R. Synthesis of prostaglandin E in rabbit eyes with topically applied epinephrine. Invest Ophthalmol Vis Sci. 1988;29:332-334.
38. Anderson L, Wilson WS. Inhibition by indomethacin of the increased facility of outflow induced by adrenaline. Exp Eye Res. 1989;50:119-126.
39. Bárány EH. Simultaneous measurements of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
40. Kaufman PL, Bárány EH. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthalmol. 1976;15:793-807.
41. Erickson-Lamy KA, Kaufman PL, McDermott ML, France NK. Comparative anesthetic effects on aqueous humor dynamics in the cynomolgus monkey. Arch Ophthalmol. 1984;102:1815-1820.
42. Erickson KA, Gonnering RS, Kaufman PL, Dortzbach RK. The cynomolgus monkey as a model for orbital research: III: Effects on ocular physiology of lateral orbitotomy and isolation of the ciliary ganglion. Curr Eye Res. 1984;3:557-564.
43. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
44. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974;58:541-548.
45. Chambers JM, Cleveland WS, Kleiner B, Tukey PA. Graphical Methods for Data Analysis. Belmont, CA: Wadsworth; 1983:191-242.
46. Kaufman PL, Rentzhog L. Effect of total iridectomy on outflow facility responses to adrenergic drugs in cynomolgus monkeys. Exp Eye Res. 1981;33:65-74.
47. Kaufman PL, Bárány EH. Adrenergic drug effects on aqueous outflow facility following ciliary muscle retrodisplacement in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1981;20:644-651.
48. Kaufman PL, Erickson KA. Cytochalasin B and D dose-outflow facility response relationships in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1982;23:646-650.
49. Robinson JC, Kaufman PL. Cytochalasin B potentiates epinephrine's outflow facility increasing effect. Invest Ophthalmol Vis Sci. 1991;32:1614-1618.
50. Robinson JC, Kaufman PL. Phalloidin inhibits epinephrine's and cytochalsin B's facilitation of aqueous outflow. Arch Ophthalmol. 1994;112:1610-1613.
51. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980;303:436-444.
52. Gabelt BT, Robinson JC, Gange SJ, Kaufman PL. Superior cervical ganglionectomy in monkeys: Aqueous humor dynamics and their responses to drugs. Exp Eye Res. 1995;60:575-584.
53. Gabelt BT, Robinson JC, Hubbard WC, et al. Apraclonidine and brimonidine effects of anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys. Exp Eye Res. 1994;59:633-644.
54. Kee C, Kaufman PL, Gabelt BT. Effect of 8-Br cGMP on aqueous humor dynamics in monkeys. Invest Ophthalmol Vis Sci. 1994;35:2769-2773.
55. Robinson JC, Kaufman PL. Dose-dependent suppression of aqueous humor formation by timolol in the cynomolgus monkey. J Glaucoma. 1993;2:251-256.
56. Croft MA, Hubbard WC, Kaufman PL. Effect of ethacrynic acid on aqueous outflow dynamics in monkeys. Invest Ophthalmol Vis Sci. 1994;35:1167-1175.
57. Sperber GO, Bill A. A method for near-continuous determination of aqueous humor flow: Effects of anaesthetics, temperature and indomethacin. Exp Eye Res. 1984;39:435-453.
58. Bill A. Effects of longstanding stepwise increments in eye pressure on the rate of aqueous humor formation in a primate (Cercopithecus ethiops). Exp Eye Res. 1971;12:184-193.
59. Kaufman PL, Bill A, Bárány EH. Formation and drainage of aqueous humor following total iris removal and ciliary muscle disinsertion in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1977;16:226-229.
60. Kaufman PL, True-Gabelt B, Erickson-Lamy KA. Time-dependence of perfusion outflow facility in the cynomolgus monkey. Curr Eye Res. 1988;7:721-726.
61. 2a-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 1989;48:707-716.
62. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49:389-402.
63. Bárány EH. Topical epinephrine effects on true outflow resistance and pseudofacility in vervet monkeys studied by a new anterior chamber perfusion technique. Invest Ophthalmol. 1968;7:88-104.
64. Acarregui MJ, Snyder JM, Mitchell MD, Mendelson CR. Prostaglandins regulate surfactant protein A (SP-A) gene expression in human fetal lung in vitro. Endocrinology. 1990;127:1105-1113.
65. Smith PL, Welsh MJ, Stoff JS, Frizzell RA. Chloride secretion by canine tracheal epithelium: I: Role of intracellular cAMP levels. J Membr Biol. 1982;70:217-226.
66. Northover BJ. The effect of indomethacin on calcium, sodium, potassium and magnesium fluxes in various tissues of the guinea-pig. Br J Pharmacol. 1972;45:651-659.
67. Neufeld AH, Sears ML. Cyclic-AMP in ocular tissues of the rabbit, monkey, and human. Invest Ophthalmol. 1974;13:475-477.
68. Harris LS, Galin MA, Lerner R. The influence of low-dose l-epinephrine on aqueous outflow facility. Ann Ophthalmol. 1970;2:455-458.
69. Kronfeld PC. Dose-effect relationships as an aid in the evaluation of ocular hypotensive drugs. Invest Ophthalmol. 1964;3:258-265.
70. Harris LS, Galin MA, Lerner R. The influence of low dose L-epinephrine on intraocular pressure. Ann Ophthalmol. 1970;2:253-257.
71. Becker B, Pettit TH, Gay AJ. Topical epinephrine therapy of open-angle glaucoma. Arch Ophthalmol. 1961; 66:219-225.
72. Alm A, Villumsen J. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol. 1991;109:1564-1568.
73. 2α-1-isopropylester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology. 1989;96:1329-1337.
74. Polansky JR, Kurtz RM, Alvarado JA, Weinreb RN, Mitchell MD. Eicosanoid production and glucocorticoid regulatory mechanisms in cultured human trabecular meshwork cells. In: Bito LZ, Stjernschantz J, eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R Liss; 1989:113-138.
75. Hecker M, Foegh ML, Ramwell PW. The eicosanoids: Prostaglandins, thromboxanes, leukotreines, and related compounds. In: Katzung BG, eds. Basic and Clinical Pharmacology. East Norwalk, CT: Appleton & Lange; 1989:228-241.
76. 2α on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res. 1990;51:87-91.
77. Bhattacherjee P, Hammond BR. Effect of indomethacin on the ocular hypotensive action of adrenaline in the rabbit. Exp Eye Res. 1977;24:307-313.
78. Kaufman PL. Pharmacologic trabeculocanalotomy: Facilitating aqueous outflow by assaulting the meshwork cytoskeleton, junctional complexes, and extracellular matrix. Arch Ophthalmol. 1992;110:34-36.
79. Tripathi BJ, Tripathi RC. Effect of epinephrine in vitro on the morphology, phagocytosis, and mitotic activity of human trabecular endothelium. Exp Eye Res. 1984;39:731-744.
80. Kaufman PL, Bárány EH. Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1977;16:47-53.
81. Svedbergh B, Lütjen-Drecoll E, Ober M, Kaufman PL. Cytochalasin B-induced structural changes in the anterior ocular segment of the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1978;17:718-734.
82. Polansky JR, Bloom E, Konami D, Weinreb RN, Alvarado JA. Cultured human trabecular cells: Evaluation of hormonal and pharmacological responses in vitro. In: Ticho U, David R, eds. Recent Advances in Glaucoma. Amsterdam: Excerpta Medica; 1984:201-206.